United States Government Printing Office printer prt distributor dst United States National Archives and Records Administration Federal Register Office author aut Government Organization text government publication eng FR Regulatory Information 1995_register executive 2010-09-25 article Notices D09002ee180a8e973 D09002ee180a8e9f1 United States Federal Trade Commission originator org United States Government Agency or Subagency In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would, among other things, prohibit a New Jersey-based consumer products company and its parents corporation (1) from representing, in any manner, directly or by implication, the efficacy of any over-the- counter product--as a contraceptive or as a method of protection against the transmission of any sexually-transmitted disease--unless, at the time of making any such representation, the companies possess and rely upon competent and reliable scientific evidence that substantiates such representation; and (2) from misrepresenting in any manner, directly or by implication, the existence, contents, validity, results, conclusions, or interpretations of any test or study relating to any over-the-counter product with a use relating to human reproduction, reproductive organs or sexually-transmitted diseases. 60 FR 55033 http://www.gpo.gov/fdsys/granule/FR-1995-10-27/95-26679 95-26679 fr27oc95-68 6750-01-M File No. 943-3277 http://www.gpo.gov/fdsys/granule/FR-1995-10-27/95-26679/content-detail.html http://www.gpo.gov/fdsys/pkg/FR-1995-10-27/html/95-26679.htm http://www.gpo.gov/fdsys/pkg/FR-1995-10-27/pdf/95-26679.pdf 3 p. 55033 55035 60 FR 55033 Johnson & Johnson Consumer Products Inc.; Consent Agreement With Analysis To Aid Public Comment; Federal Register Vol. 60, Issue NOTICE 95-26679 FEDERAL TRADE COMMISSION 1995-12-26 File No. 943-3277 6750-01-M 95-26679 Consent agreement.

In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would, among other things, prohibit a New Jersey-based consumer products company and its parents corporation (1) from representing, in any manner, directly or by implication, the efficacy of any over-the- counter product--as a contraceptive or as a method of protection against the transmission of any sexually-transmitted disease--unless, at the time of making any such representation, the companies possess and rely upon competent and reliable scientific evidence that substantiates such representation; and (2) from misrepresenting in any manner, directly or by implication, the existence, contents, validity, results, conclusions, or interpretations of any test or study relating to any over-the-counter product with a use relating to human reproduction, reproductive organs or sexually-transmitted diseases.

Comments must be received on or before December 26, 1995. Linda K. Badger, San Francisco Regional Office, 901 Market Street, Suite 570, San Francisco, California 94103. (415) 356-5270. Vol. 60, no. 208 Office of the Federal Register, National Archives and Records Administration 1995-10-27 continuing daily deposited born digital 244 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 http://www.gpo.gov/fdsys/pkg/FR-1995-10-27 P0b002ee180a8e8cd 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr27oc95 http://www.gpo.gov/fdsys/pkg/FR-1995-10-27/content-detail.html http://www.gpo.gov/fdsys/pkg/FR-1995-10-27/pdf/FR-1995-10-27.pdf fdlp 54937 55172 DGPO 2010-07-15 2010-07-15 FR-1995-10-27 machine generated eng FR FR-1995-10-27 60 208